Toceranib

(Z)-5-(5-Fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide
98% ( CHEMICELL)
CAS号 356068-94-5 试剂别名 Z)-5-(5-氟-2-氧代-2,3-二氢-1H-吲哚-3-亚基甲基)-2,4-二甲基-N-[2-(1-吡咯烷基)乙基]-1H-吡咯-3-甲酰胺;(Z)-5-(5-氟-2-氧代-2,3-二氢-1H-吲哚-3-亚基甲基)-2,4-二甲基-N-[2-(1-吡咯烷基)乙基]-1H-吡咯-3-甲酰胺;5'-O-乙酰基-2'3'-O-异亚丙基腺苷
分子式 C22H25FN4O2
分子量 396.46
英文名称: (Z)-5-(5-Fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide
英文别名: (Z)-5-(5-Fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide;Toceranib;(Z)-5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-N-(2-(pyrrolidin-1-yl)ethyl)-1H-pyrrole-3-carboxamide;5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide;SU-11654;Toceranib Discontin;ToceranibDiscontinued Pfizer Patent issues;5-(5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide;5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide;PHA 291639;PHA-291639;SU 11654;5-[(5Z)-(5-Fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-carboxamide;SU11654;5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide
中文别名: Z)-5-(5-氟-2-氧代-2,3-二氢-1H-吲哚-3-亚基甲基)-2,4-二甲基-N-[2-(1-吡咯烷基)乙基]-1H-吡咯-3-甲酰胺;(Z)-5-(5-氟-2-氧代-2,3-二氢-1H-吲哚-3-亚基甲基)-2,4-二甲基-N-[2-(1-吡咯烷基)乙基]-1H-吡咯-3-甲酰胺;5'-O-乙酰基-2'3'-O-异亚丙基腺苷
CAS No.: 356068-94-5
分子式: C22H25FN4O2
分子量: 396.46
纯度: 98%

相关产品